Drugs
-
Selective Serotonin Reuptake Inhibitors (SSRIs) Information
This class of drugs is used to treat depression, anxiety, and other mood disorders.
Marketed under various brand and generic drug names
| Generic name | Found in Brand name(s) |
|---|---|
| Citalopram | Celexa |
| Escitalopram | Lexapro |
| Fluoxetine | Prozac, Sarafem, Symbyax |
| Fluvoxamine | Luvox, Luvox CR |
| Paroxetine | Paxil, Paxil CR, Pexeva |
| Sertraline | Zoloft |
| Vilazodone | Viibryd |
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program, using the contact information at the bottom of this page.
-
-
-
Additional Information
FDA Drug Safety Communication: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies
12/14/2011FDA Drug Safety Podcast for Healthcare Professionals: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies
12/14/2011Comunicado de la FDA sobre la seguridad de los medicamentos: El uso de antidepresivos con inhibidor selectivo de recaptación de serotonina (SSRI por sus siglas en inglés) durante el embarazo y reportes de afecciones cardiacas y pulmonares poco comunes en recién nacidos
12/14/2011Antidepressant Use in Children, Adolescents, and Adults
5/2007Public Health Advisory: Treatment Challenges of Depression in Pregnancy and the Possibility of Persistent Pulmonary Hypertension in Newborns
7/2006- Public Health Advisory: Combined Use of 5-Hydroxytryptamine Receptor Agonists (Triptans), Selective Serotonin Reuptake Inhibitors (SSRIs) or Selective Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs) May Result in Life-threatening Serotonin Syndrome
7/2006
-
-
-
